The cost-effectiveness of bisphosphonates in metastatic breast cancer: letter to the editor in response to Botteman et al. 2006.
Souberbielle
B
B
Williams
R
R
McCloskey
E
E
D001859:Bone Neoplasms / Q000191:economics* / Q000556:secondary; D001943:Breast Neoplasms / Q000191:economics* / Q000473:pathology; D003362:Cost-Benefit Analysis; D004164:Diphosphonates / Q000191:economics*; D005260:Female; D006801:Humans
D004164:Diphosphonates